5B5K.8ICD-11 MMS 2026-01
Chromium deficiency
Description
Deficiency in humans is only described in long-term total parenteral nutrition patients receiving insufficient chromium. Hyperglycaemia or impaired glucose tolerance occurs. Elevated plasma free fatty acid concentrations, neuropathy, encephalopathy, and abnormalities in nitrogen metabolism are also reported.
Index terms
- Chromium deficiency
Exclusions from above levels
Sibling codes
5B5K.0– Iron deficiency5B5K.1– Calcium deficiency5B5K.2– Zinc deficiency5B5K.3– Iodine deficiency5B5K.4– Fluorine deficiency5B5K.5– Sodium chloride deficiency5B5K.6– Copper deficiency5B5K.7– Selenium deficiency5B5K.9– Manganese deficiency5B5K.A– Molybdenum deficiency5B5K.B– Vanadium deficiency5B5K.Y– Other specified mineral deficiency5B5K.Z– Mineral deficiency, unspecified
Foundation entity
Chromium deficiency – http://id.who.int/icd/entity/2006854546
Part of: 5B5K: Mineral deficiencies › 05: Endocrine, nutritional or metabolic diseases